Drug-induced QT prolongation

Drug-induced QT prolongation is a significant alteration in cardiac function, where the QT interval on an electrocardiogram (ECG) is extended beyond the normal range as a result of medication intake. The QT interval represents the time it takes for the heart's ventricles to depolarize and repolarize, essentially measuring the time from the start of the Q wave to the end of the T wave in the heart's electrical cycle. Prolongation of this interval can increase the risk of developing arrhythmias, particularly Torsades de Pointes (TdP), a potentially life-threatening condition.

Causes

Drug-induced QT prolongation can be caused by a variety of medications, including but not limited to certain antibiotics, antidepressants, antipsychotics, and antiarrhythmic drugs. The mechanism behind this adverse effect often involves the blockade of the hERG (human Ether-à-go-go-Related Gene) channel, which is crucial for cardiac repolarization. By inhibiting this channel, drugs can inadvertently prolong the QT interval.

Risk Factors

Several factors can increase the risk of drug-induced QT prolongation, including:

• Female gender
• Advanced age
• Existing heart conditions
• Electrolyte imbalances, particularly low levels of potassium or magnesium
• Concurrent use of multiple medications that prolong the QT interval

Symptoms

In many cases, drug-induced QT prolongation is asymptomatic. However, when symptoms do occur, they may include:

• Palpitations
• Fainting (syncope)
• Seizures

In severe cases, it can lead to Torsades de Pointes (TdP), a specific type of ventricular tachycardia that can degenerate into ventricular fibrillation and sudden death.

Diagnosis

Diagnosis of drug-induced QT prolongation involves a thorough medical history, medication review, and an ECG. The QT interval is measured, and if prolonged, the offending medication may be identified and discontinued.

Management

Management of drug-induced QT prolongation primarily involves:

• Discontinuation of the offending medication
• Correction of electrolyte imbalances
• Close monitoring of the QT interval

In some cases, alternative medications that do not affect the QT interval may be prescribed.

Prevention

Prevention strategies include:

• Careful selection of medications, especially in patients with known risk factors
• Regular monitoring of the QT interval in patients taking medications known to cause QT prolongation
• Avoiding the concurrent use of multiple QT-prolonging drugs

See Also

• Electrocardiography
• Torsades de Pointes
• Arrhythmia
• Cardiac electrophysiology

Stub icon

   This article is a Cardiovascular system drug stub. You can help WikiMD by expanding it!

```

This template is designed to be used at the bottom of articles related to drugs for the cardiovascular system that are considered stubs, indicating that the article is a short or incomplete piece that can be expanded with more information. The template includes a link to the main category for cardiovascular system drug stubs, encouraging users to help expand these articles.